King & Spalding LLP represents clients in every segment of the life sciences industry in high-stakes product liability, class action, and mass torts. Leveraging its cross-practice expertise, the team collaborates closely with appellate, regulatory, and life science lawyers. It regularly serves as national and regional coordinating counsel, and its strategic resolution team has favorably resolved large litigations. The practice is led by Atlanta’s Andy Bayman, who serves as lead counsel for Boehringer Ingelheim in litigation involving Zantac; and Houston’s Tracie Renfroe, who represents clients in federal and state civil jury trials, MDLs, and class actions. TaCara Harris, in Atlanta, chairs the firm's pharmaceutical & medical device litigation practice group. Shaila Rahman Diwan departed the team in May 2025.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Becton Dickinson
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Eli Lilly & Company
- GlaxoSmithKline
- Johnson & Johnson/Janssen Pharmaceuticals, Inc.
- Kenvue, fka Johnson & Johnson Consumer Inc.
- Organon
- Walmart, Inc.
Highlight-Mandate
Serves as national coordinating and trial counsel for Boehringer Ingelheim in all litigation alleging its heartburn medication Zantac increases the risk of cancer.
Served as national counsel for Walmart in litigation alleging that manufacturers of Tylenol and retailers of private-labeled acetaminophen products failed to warn pregnant mothers about the potential risks to their children of prenatal exposure to the drugs.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Andy Bayman; Tracie Renfroe
Weitere Kernanwält*innen
TaCara Harris